Evidence map›Paper›PMID 11748222›Full record

ArticleThe Journal of biological chemistry2002

Functional interaction between coactivators CBP/p300, PCAF, and transcription factor FKLF2.

Chao-Zhong Song, Kimberly Keller, Ken Murata, Haruhiko Asano, George Stamatoyannopoulos

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Putative tumor-suppressive function of Kruppel-like factor 4 in primary lung carcinoma.Clinical cancer research : an official journal of the American Association for Cancer Research · 2009
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Chao-Zhong SongDivision of Medical Genetics, Department of Medicine, University of Washington, Seattle, WA 98195, USA.
Kimberly Keller
Ken Murata
Haruhiko Asano
George Stamatoyannopoulos
University of Washington Medical Center · USNagoya University · JP

Funding

CELLULAR MECHANISMS OF HB F REGULATIONR01HL020899 · NHLBI · UNIVERSITY OF WASHINGTON · PI STAMATOYANNOPOULOS, GEORGE · 1985 to 2007
$3.6M
MOLECULAR CONTROL OF HUMAN GLOBIN GENE SWITCHINGR01DK045365 · NIDDK · UNIVERSITY OF WASHINGTON · PI STAMATOYANNOPOULOS, GEORGE · 1992 to 2011
$1.6M
NHLBI NIH HHS R01 HL020899NIDDK NIH HHS R01 DK045365
6 · The paper itself

Abstract

The Sp1/KLF family of factors regulates diverse cellular processes, including growth and development. Fetal Krüppel-like factor (FKLF2) is a new member of this family. In this study, we characterized the coactivators involved in FKLF2 transcriptional activation. Our results show that both CBP/p300 and p300/CBP-associated factor (PCAF) enhance FKLF2 transcriptional activity. We demonstrate that the acetyltransferase activity of PCAF but not that of CBP/p300 is required for stimulating FKLF2 transcription activity. We further show that p300 and PCAF act cooperatively in stimulating FKLF2 transcriptional activation. FKLF2 interacts with both CBP and PCAF through specific domains, and CBP and PCAF acetylate FKLF2. Both CBP/p300 and PCAF stimulate FKLF2 DNA binding activity. The integrity of the acetyltransferase domain of PCAF but not that of CBP/p300 is required for stimulating FKLF2 DNA binding activity. These results demonstrate that CBP/p300 and PCAF stimulate FKLF2 transcriptional activity at least by enhancing its DNA binding. The acetyltransferase activities of CBP/p300 and PCAF play a distinct role in stimulating FKLF2 transcription and DNA binding.

Indexed as

Repressor ProteinsSaccharomyces cerevisiae ProteinsAcetyltransferasesAnimalsCell Cycle ProteinsCOS CellsDNAGlobinsGlutathione TransferaseHistone AcetyltransferasesHumansK562 CellsKruppel-Like Transcription FactorsLuciferasesp300-CBP-Associated Factorp300-CBP Transcription FactorsAcetyltransferasesCell Cycle ProteinsDNAGlobinsGlutathione TransferaseHistone AcetyltransferasesKLF13 protein, humanKruppel-Like Transcription FactorsLuciferasesp300-CBP-Associated Factorp300-CBP Transcription FactorsRepressor ProteinsSaccharomyces cerevisiae ProteinsTrans-ActivatorsTranscription Factors

Identifiers

PMID11748222
PMCPMC2808425
OpenAlexW2135501426

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.